Initially approved by the FDA in 2013, memantine is an N-methyl-D-aspartate (NMDA) receptor antagonist used in the management of Alzheimer's Disease (AD). It is different from many other Alzheimer's Disease medications, as it works by a different mechanism than the cholinesterase enzyme inhibitors normally employed in the management of Alzheimer's disease . ...
Memantine is used to manage moderate to severe Alzheimer's dementia .
...
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.